Abstract
At low concentrations of DMBA (½% and 1%) twice as many sarcomas and carcinomas of the salivary glands are induced in male as in female rats. Additional oestrogens reduce neoplasms in males by one half while testosterone doubles them in females. The sex difference disappears at the higher dose levels of the carcinogen (2%).
Females are more sensitive than males to the toxic effects of DMBA, though less sensitive to the carcinogenic action.
Carcinomas rise to a single peak within 240 days while sarcomas appear as late as 770 days with secondary and tertiary peaks. This difference in pattern of induction may be due to the formation of a fibrous capsule separating persisting DMBA-deposits from the epithelial structures and thus protecting them from carcinogenic risk.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cherry C. P., Glücksmann A. The histogenesis of carcinomas and sarcomas induced in the salivary glands of rats. Br J Cancer. 1965 Dec;19(4):787–801. doi: 10.1038/bjc.1965.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glucksmann A., Cherry C. P. The effect of thyroactive substances on the induction of cervico-vaginal and vulval tumours in castrate rats at various levels of carcinogenic treatment. Br J Cancer. 1970 Dec;24(4):769–784. doi: 10.1038/bjc.1970.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- REUBER M. D. Endometrial sarcomas of the uterus and carcinosarcomas of the submaxillary salivary gland in castrated A xC strain female rats receiving N,N-fluorenyldiacetamide and norethandrolone. J Natl Cancer Inst. 1960 Nov;25:1141–1153. [PubMed] [Google Scholar]